Home Tags Inozyme Pharma Secures Flexible Debt Facility for up to $70 Million with K2 HealthVentures
Tag: Inozyme Pharma Secures Flexible Debt Facility for up to $70 Million with K2 HealthVentures
Inozyme Pharma Secures Flexible Debt Facility for up to $70 Million...
BOSTON, July 26, 2022 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment...